For the first time in our history, the American Cancer Society research budget is in jeopardy. As a direct result of COVID-19, deep cuts to our research funding could mean a generation of cancer research lost. We need your help now in these priority areas because...


cancer diagnoses
decrease and life

everyone has a fair 

and just opportunity 

to survive cancer

affordable, high-quality treatments move from lab to bedside quickly

there is no such
thing as terminal

Health Equity &

Social Determinants of Health 

  • Data shows that racial and ethnic minorities, members of the LGBTQ+ community and those with lower socioeconomic status have a disproportionate cancer burden

  • ACS is slated to fund close to 60 grants in 2020 focused on health equity research and eliminating those disparities

  • Grants are focused on how social determinants impact cancer incidence; how they impact access to care; how they impact outcomes of care; how they impact survivorship & quality of life

  • Only 7% of NIH applicants are from underrepresented minority groups and less than 2% are Black Americans. 

  • Through our Diversity Research Internship program we ensure college students of diverse backgrounds who are underrepresented in the cancer research field see medical research as a potential career opportunity.

Cancer Research & Preserving a Generation of Breakthroughs

  • ACS invests in early-career investigators so they can establish their science to secure larger federal grant funding

  • ACS invests in innovative and out of the box ideas across the cancer continuum

  • More than $100 million of cancer research is at risk

  • Failing to invest in research now means that we will have fewer preventative tools, fewer treatment options, lost progress towards a cure, and ultimately, more deaths from cancer in the future.

  • Research takes years to come to fruition; a cancer breakthrough begins perhaps 10-20 years earlier. 

  • A lack of available funding could deter young investigators with big ideas to leave the field for different careers. 

  • If research is disrupted today, it means lives lost tomorrow.

American Cancer Society | PA CEOs Against Cancer | 1818 Market Street, Suite 2820, Philadelphia PA 19103 | Contact: 215.985.5401


In the United States, call for cancer information: 1.800.ACS.2345 · Copyright © 2019 American Cancer Society, Inc. · All content and works posted on this Website are owned and copyrighted by the American Cancer Society, Inc. All rights reserved.

The official registration and financial information of the American Cancer Society may be obtained from the Pennsylvania Department of State by calling toll free, within Pennsylvania, 1.800.732.0999. Registration does not imply endorsement.